6:39 PM
 | 
Feb 27, 2007
 |  BC Extra  |  Top Story

Panel backs sanofi's H5N1 vaccine

FDA's Vaccines and Related Biological Products Advisory Committee voted on Tuesday to recommend approval of an H5N1 pandemic influenza vaccine from sanofi-aventis (Euronext:SAN; SNY). The committee voted 14-0 and 13-1 that data in the BLA were sufficient to support the vaccine's efficacy and safety,...

Read the full 200 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >